(Image from Heraeus Medical Components)
Heraeus Medical Components (St. Paul, Minn.) and Toronto-based Myant have entered a partnership enabling Myant to use Heraeus’ Tectitoat for electrical sensing applications in textiles, the companies announced today.
Tecticoat is a conductive polymer-based coating that can be applied to textiles to control electrical conductivity, electromagnetic shielding and electrostatic dissipation, making it suitable for integration into connected, on-skin textile applications, according to Heraeus. Tecticoat is also flexible and medically formulated and can be applied to yarns like the ones developed by Myant for its bioelectrical on-skin sensing (e.g. ECG, EEG, EMG) textile applications.
“The quality of data collected from the human body is highly dependent on the quality of the interface between the electrode and the skin,” said Myant CEO Tony Chahine in a news release. “This partnership with Heraeus to develop a solution using Tecticoat takes us another step closer to building a better bidirectional connection to the human body via textiles.”
“We are excited to enter into this partnership with Myant to develop solutions using Tecticoat,” added Heiko Specht, EVP of stimulation and sensing solutions and global innovation at Heraeus. “This partnership reflects our reputation and history as a leader in materials for advanced technological applications and we look forward to leveraging Myant’s experience in technology integration and yarn-based textile production to further explore Tecticoat’s use in wearables.”
